HC Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $210K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $285K | Sell |
|
|||||
|
2023
Q1 | $223K | Sell |
|
|||||
|
2022
Q4 | $296K | Sell |
|
|||||
|
2022
Q3 | $2.83M | Buy |
|
|||||
|
2022
Q2 | $325K | Buy |
|
|||||
|
2022
Q1 | $350K | Sell |
|
|||||
|
2021
Q4 | $570K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $209K | Sell |
|
|||||
|
2021
Q1 | $237K | Sell |
|
|||||
|
2020
Q4 | $327K | Buy |
|